Antibiotics | KE-Y1 Wild-type | KE-Y3 Transposon mutant | KE-Y3 + pADY123::ampG | KE-Y6 Transposon mutant | KEY6 + pADY123::ampG | KE- Y1ΔampG |
---|---|---|---|---|---|---|
Ampicillin | ≥ 32(R) | ≥ 32(R) | ≥ 32(R) | ≤ 2*(R*) | ≥ 32(R) | ≤ 4(S) |
SAM | ≥ 32(R) | ≤ 2(R*) | ≥ 32(R) | ≤ 2(R*) | ≥ 32(R) | ≤ 2(S) |
TZP | ≥ 128(R) | ≤ 4(S) | ≥ 128(R) | ≤ 4(S) | ≥ 128(R) | ≤ 4(S) |
Cefazolin | ≥ 64(R) | 32(R) | ≥ 64(R) | 16 (R*) | ≥ 64(R) | 32(R) |
Cefoxitin | ≥ 64(R) | ≥ 64(R) | ≥ 64(R) | ≥ 64(R) | ≥ 64(R) | ≥ 64(R) |
Cefotaxime | ≥ 64(R) | ≤ 1(S) | ≥ 64(R) | ≤ 1(S) | ≥ 64(R) | ≤ 1(S) |
Ceftazidime | ≥ 64(R) | ≤ 1(S) | 32(R) | ≤ 1(S) | ≥ 64(R) | ≤ 1(S) |
Cefepime | ≤ 1(S) | ≤ 1(S) | ≤ 1(S) | ≤ 1(S) | 2(S) | ≤ 1(S) |
Aztreonam | ≥ 64(R) | ≤ 1(S) | 32(R) | ≤ 1(S) | ≥ 64(R) | ≤ 1(S) |
Ertapenem | ≥ 8(R) | ≤ 0.5(S) | ≥ 8(R) | ≤ 0.5(S) | ≥ 8(R) | ≤ 0.5(S) |
Meropenem | 8(R) | ≤ 0.25(S) | 2(I) | ≤ 0.25(S) | 4(R) | ≤ 0.25(S) |
Amikacin | ≤ 2(S) | ≤ 2(S) | ≤ 2(S) | ≤ 2(S) | ≤ 2(S) | ≤ 2(S) |
Gentamicin | ≤ 1(S) | ≥ 16(R) | ≥ 16(R) | ≥ 16(R) | ≥ 16(R) | ≤ 1(S) |
Levofloxacin | ≤ 0.12(S) | ≤ 0.12(S) | ≤ 0.12(S) | ≤ 0.12(S) | ≤ 0.12(S) | ≤ 0.12(S) |
Tigecycline | 1(S) | ≤ 0.5(S) | ≤ 0.5(S) | ≤ 0.5(S) | ≤ 0.5(S) | ≤ 0.5(S) |
TMP/SMX | ≤ 20(S) | ≤ 20(S) | ≤ 20(S) | ≤ 20(S) | ≤ 20(S) | ≤ 20(S) |